165 related articles for article (PubMed ID: 36269109)
1. An International Consensus on Actions to Improve Lung Cancer Survival: A Modified Delphi Method Among Clinical Experts in the International Cancer Benchmarking Partnership.
Lynch C; Harrison S; Butler J; Baldwin DR; Dawkins P; van der Horst J; Jakobsen E; McAleese J; McWilliams A; Redmond K; Swaminath A; Finley CJ
Cancer Control; 2022; 29():10732748221119354. PubMed ID: 36269109
[TBL] [Abstract][Full Text] [Related]
2. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Role of Leadership in Facilitating Change to Improve Cancer Survival: An Analysis of Experiences in Seven High Income Countries in the International Cancer Benchmarking Partnership (ICBP).
Morris M; Seguin M; Landon S; McKee M; Nolte E
Int J Health Policy Manag; 2022 Sep; 11(9):1756-1766. PubMed ID: 34380203
[TBL] [Abstract][Full Text] [Related]
4. The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom.
Butler J; Foot C; Bomb M; Hiom S; Coleman M; Bryant H; Vedsted P; Hanson J; Richards M;
Health Policy; 2013 Sep; 112(1-2):148-55. PubMed ID: 23693117
[TBL] [Abstract][Full Text] [Related]
5. Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP).
Menon U; Vedsted P; Zalounina Falborg A; Jensen H; Harrison S; Reguilon I; Barisic A; Bergin RJ; Brewster DH; Butler J; Brustugun OT; Bucher O; Cairnduff V; Gavin A; Grunfeld E; Harland E; Kalsi J; Knudsen AK; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Weller D
BMJ Open; 2019 Nov; 9(11):e025895. PubMed ID: 31776134
[TBL] [Abstract][Full Text] [Related]
6. Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Barclay ME; Swann R; Johnson SA; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; Kumar SE; May L; McClure CA; Morrison DS; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJ; Wang H; Woods RR; You H; Zhang B; Lyratzopoulos G;
Lancet Oncol; 2024 Mar; 25(3):352-365. PubMed ID: 38423049
[TBL] [Abstract][Full Text] [Related]
7. Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Barclay ME; Johnson SA; Swann R; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; May L; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJS; Thomson CS; Wang H; Woods RR; You H; Lyratzopoulos G;
Lancet Oncol; 2024 Mar; 25(3):338-351. PubMed ID: 38423048
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
[TBL] [Abstract][Full Text] [Related]
9. Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership.
Lynch C; Harrison S; Emery JD; Clelland C; Dorman L; Collins C; Johansen ML; Lawrenson R; Surgey A; Weller D; Jarbøl DE; Balasubramaniam K; Nicholson BD
Br J Gen Pract; 2023 Feb; 73(727):e88-e94. PubMed ID: 36127155
[TBL] [Abstract][Full Text] [Related]
10. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.
Rose PW; Rubin G; Perera-Salazar R; Almberg SS; Barisic A; Dawes M; Grunfeld E; Hart N; Neal RD; Pirotta M; Sisler J; Konrad G; Toftegaard BS; Thulesius H; Vedsted P; Young J; Hamilton W; ;
BMJ Open; 2015 May; 5(5):e007212. PubMed ID: 26017370
[TBL] [Abstract][Full Text] [Related]
11. "There's Not Enough Bodies to Do the Demand": An Exploration of Key Stakeholder Views on the Role of Health Service Capacity in Shaping Cancer Outcomes in 7 International Cancer Benchmarking Partnership Countries.
Seguin M; Morris M; McKee M; Nolte E
Int J Health Policy Manag; 2022 Jul; 11(7):1024-1034. PubMed ID: 33589567
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis: international variation in PET-CT service provision in oncology-an International Cancer Benchmarking Partnership study.
Lynch C; Reguilon I; Langer DL; Lane D; De P; Wong WL; Mckiddie F; Ross A; Shack L; Win T; Marshall C; Revheim ME; Danckert B; Butler J; Dizdarevic S; Louzado C; Mcgivern C; Hazlett A; Chew C; O'connell M; Harrison S
Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 33306102
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP).
Weller D; Menon U; Zalounina Falborg A; Jensen H; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Gavin AT; Grunfeld E; Harland E; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Harrison S; Reguilon I; ; Vedsted P
BMJ Open; 2018 Nov; 8(11):e023870. PubMed ID: 30482749
[TBL] [Abstract][Full Text] [Related]
14. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
15. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
16. Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions.
Eden M; Harrison S; Griffin M; Lambe M; Pettersson D; Gavin A; Brewster DH; Lin Y; Johannesen TB; Milne RL; Farrugia H; Nishri D; King MJ; Huws DW; Warlow J; Turner D; Earle CC; Peake M; Rashbass J
Cancer Epidemiol; 2019 Feb; 58():184-192. PubMed ID: 30639877
[TBL] [Abstract][Full Text] [Related]
17. Prioritising models of healthcare service delivery for a more sustainable health system: a Delphi study of Australian health policy, clinical practice and management, academic and consumer stakeholders.
Putrik P; Jessup R; Buchbinder R; Glasziou P; Karnon J; O Connor DA
Aust Health Rev; 2021 Aug; 45(4):425-432. PubMed ID: 33731250
[TBL] [Abstract][Full Text] [Related]
18. Consensus study on the health system and patient-related barriers for lung cancer management in South Africa.
Mapanga W; Norris SA; Chen WC; Blanchard C; Graham A; Baldwin-Ragaven L; Boyles T; Donde B; Greef L; Huddle K; Khumalo B; Leepile E; Lubuzo B; Makhutle R; Mayet Y; Tsitsi M; Mistri P; Mmoledi K; Ratshikana-Moloko M; Morer R; Pretorius L; Punwasi J; Richards GA; Ruff P; Shabalala D; Sibadela M; Soma N; Wong M; Joffe M
PLoS One; 2021; 16(2):e0246716. PubMed ID: 33571312
[TBL] [Abstract][Full Text] [Related]
19. Consensus minimum data set for lung cancer multidisciplinary teams: Results of a Delphi process.
Stone E; Rankin N; Phillips J; Fong K; Currow DC; Miller A; Largey G; Zielinski R; Flynn P; Shaw T
Respirology; 2018 Oct; 23(10):927-934. PubMed ID: 29641841
[TBL] [Abstract][Full Text] [Related]
20. Five ways to improve international comparisons of cancer survival: lessons learned from ICBP SURVMARK-2.
Andersson TM; Myklebust TÅ; Rutherford MJ; Møller B; Arnold M; Soerjomataram I; Bray F; Parkin DM; Lambert PC
Br J Cancer; 2022 May; 126(8):1224-1228. PubMed ID: 35058590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
